At Heart Rhythm 2012, Dr. James Reiffel gave us an update on new medications for treating atrial fibrillation, including the combination of low doses of ranolazine (Ranexa) and dronedarone (Multaq). He also talked about rate control vs. rhythm control for afib, and how the decision can vary by age and level of symptoms.
Watch the video or read the transcript at:
New Atrial Fibrillation Treatments and Rate vs. Rhythm Control for Afib — Video Interview with Dr. James Reiffel
Leave a Reply